‘Robotability score’ ranks NYC streets for future robot deployment

The rating system is the first of its kind and may help urban planners and robotics companies plan for future robot deployments that won’t disrupt existing sidewalk environments.

Personalized AI tools can combat ableism online

New Cornell research reveals that social media users with disabilities prefer more personalized content moderation powered by AI systems that not only hide harmful content but also summarize or categorize it by the specific type of hate expressed.

Three-dimensional gene hubs may promote brain cancer

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers. 

Bala, Agrawal, Pascual elected to arts and sciences academy

Provost Kavita Bala and professors Anurag Agrawal and Dr. M. Virginia Pascual have been elected to the American Academy of Arts and Sciences, the academy announced on April 23.

Home care workers unaware of AI’s role and potential benefits

Researchers found that home care workers, care agency staff and worker advocates lack understanding of AI technology, its data usage and the reasons AI systems retain their information.

Study finds protein partnership protects chromosomes

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy.

Cornell Tech alumni create New York City law firm to transform law with tech

Three alumni from Cornell Tech’s Master of Laws (LL.M.) in Law, Technology, and Entrepreneurship program have joined forces at ALVK Law.

Around Cornell

Gut microbes release cancer-fighting bile acids

Bacteria naturally present in the human intestine can transform cholesterol-derived bile acids into powerful metabolites that strengthen anticancer immunity by blocking androgen signaling, according to a preclinical study.

New strategy may enable cancer monitoring from blood tests alone

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment.